BOESS CARSTEN bought RNA
February 27, 2026 · Form 4 insider transaction
BOESS CARSTEN bought 20,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderBOESS CARSTEN
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 2, 2026
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.